Schafer Looks Ahead in the Latest Issue of Market Access Spotlight
Jeremy Schafer, director of Precision’s Payer Access Solutions, shares his thoughts on drug pricing, M&A activity, 340B changes, and other things top-of-mind for 2018. (more…)
February Issue of Precision’s All Access Available Now
The February issue of All Access, Precision’s free newsletter featuring articles by former payers written specifically for market access leaders, is now available. (more…)
Precision Value & Health Acquires Leading Market Access Consultancy Insight Strategy Advisors
ADDITION OF NEW YORK-BASED FIRM COMPLEMENTS AND STRATEGICALLY EXPANDS PRECISION’S EXISTING GLOBAL MARKET ACCESS EXPERTISE AND CAPABILITIES
New York, NY – Tuesday, January 30, 2018 – Precision Value & Health today announced it is acquiring Insight Strategy Advisors (ISA), a New York-based leading market access consultancy supporting value demonstration, pricing, reimbursement, and distribution for biopharmaceutical companies. ISA will become part of Precision Xtract, the global market access consultancy within Precision Value & Health.
Schafer Discusses Improving Cancer Drug Accessibility with Managed Healthcare Executive
Jeremy Schafer, SVP, Director of Precision’s Payer Access Solutions, offers advice to healthcare executives on helping patients get access to crucial new cancer drugs. (more…)
Kohler and Guennel Discuss Biomarker Drug Development & New FDA Data Requirements in Regulatory Focus
Precision for Medicine’s Jared Kohler and Tobias Guennel highlight the challenges for researchers pursuing biomarkers and specialty lab data that meet new FDA regulatory standards. (more…)